[Federal Register Volume 83, Number 204 (Monday, October 22, 2018)]
[Notices]
[Page 53277]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-22902]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Complementary and Integrative Health; Notice 
of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended notice is hereby given of a meeting of the Special Emphasis 
Panel.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Complementary and 
Integrative Health Special Emphasis Panel, Early Phase Clinical 
Trials of Natural Products (NP).
    Date: November 29, 2018.
    Time: 12:00 p.m. to 2:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Martina Schmidt, Ph.D., Chief, Office of 
Scientific Review, National Center for Complementary and Integrative 
Health, NIH, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892, 
301-594-3456, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.213, 
Research and Training in Complementary and Integrative Health, 
National Institutes of Health, HHS)

    Dated: October 16, 2018.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-22902 Filed 10-19-18; 8:45 am]
 BILLING CODE 4140-01-P